Abstract | OBJECTIVE: METHOD: Forty patients with psoriasis vulgaris were recruited; 20 were treated with flumetasone ointment plus 308-nm excimer laser therapy, and the other 20 received only excimer laser monotherapy. The flumetasone ointment was applied topically twice a day, and laser treatments were scheduled twice weekly for a total of 10 treatments. Clinical efficacy was evaluated in a blinded manner by two independent physicians using photographs taken before and after treatment. RESULTS: Of the 40 patients who received and completed the entire course of therapy, the psoriasis area and severity index score was improved by 82.51 ± 11.24% and 72.01 ± 20.94% in the combination group and laser group, respectively (P > 0.05), and the average cumulative dose was 5.06 ± 2.20 j/cm(2) in the combination group and 7.75 ± 2.25 j/cm(2) in the laser-only group, respectively (P < 0.05). CONCLUSION: The clinical data suggest that combination treatment using flumetasone ointment and a 308-nm excimer laser is superior to laser monotherapy for treatment of psoriasis vulgaris. The combination therapy can increase effectiveness and decrease the total laser dose, thus potentially reducing side effects.
|
Authors | Jie Dong, Yanling He, Xiuying Zhang, Yixuan Wang, Yongjing Tian, Jie Wang |
Journal | Photodermatology, photoimmunology & photomedicine
(Photodermatol Photoimmunol Photomed)
Vol. 28
Issue 3
Pg. 133-6
(Jun 2012)
ISSN: 1600-0781 [Electronic] England |
PMID | 22548394
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Copyright | © 2012 John Wiley & Sons A/S. |
Chemical References |
- Anti-Inflammatory Agents
- Keratolytic Agents
- Ointments
- Flumethasone
- Salicylic Acid
|
Topics |
- Administration, Topical
- Adult
- Anti-Inflammatory Agents
(administration & dosage)
- Female
- Flumethasone
(administration & dosage)
- Humans
- Keratolytic Agents
(administration & dosage)
- Laser Therapy
(methods)
- Male
- Middle Aged
- Ointments
- Psoriasis
(therapy)
- Salicylic Acid
(administration & dosage)
- Time Factors
|